Mahmoud Elkazzaz works as a clinical researcher (Principal Investigator) at Kafrelsheikh
University's College of Medicine : Egypt. He earned a B.Sc and an M.Sc in Chemistry and
Biochemistry from Damietta University : Faculty of Science : Egypt. His master's thesis
focused on evaluating and assessing the fold change of MicRNA 223 as a novel biomarker
for the early detection of Hepatocellular Carcinoma(HCC) in hepatic patients infected with
hepatitis C virus (HCV). At present time, He works as part of a clinical trial team that
includes biomedical scientists who investigate medication potency, efficacy, side effects,
dosing , as well as drug impact on study volunteers. In cooperation with this research team,
he conducted many clinical studies. The focus of these clinical studies is immunity to
COVID- 19 as an emerging viral pathoge